Shares closed at $560.11 on Friday, marking a second straight daily loss, even as the S&P 500 rose 0.84% and the Dow added 0.02%.
The stock finished 27.26% below its 52-week high of $769.98 reached on 26 November, underperforming in a broadly strong market session.
Among peers, Johnson & Johnson fell 0.53%, Medtronic dropped 2.32% and Boston Scientific lost 4.67%, while IDEXX trading volume stayed below its 50-day average.
IDEXX beat earnings and raised guidance, so why is its stock price still dropping?
As U.S. vet visits decline, can IDEXX's AI-powered tech really save its growth trajectory?